Laxmi Dental Ltd
Incorporated in 2004, Laxmi Dental is an integrated dental products company offering a comprehensive portfolio of Dental Products[1]
- Market Cap ₹ 1,686 Cr.
- Current Price ₹ 307
- High / Low ₹ 584 / 302
- Stock P/E 65.4
- Book Value ₹ 41.7
- Dividend Yield 0.00 %
- ROCE 19.2 %
- ROE 21.9 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 57.5% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 32.4%
Cons
- Stock is trading at 7.35 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies
Part of BSE Healthcare BSE SmallCap BSE IPO BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 150 | 92 | 137 | 162 | 194 | 239 | 260 | |
| 146 | 88 | 130 | 152 | 169 | 196 | 218 | |
| Operating Profit | 3 | 4 | 7 | 9 | 24 | 43 | 42 |
| OPM % | 2% | 5% | 5% | 6% | 13% | 18% | 16% |
| 2 | 0 | -10 | 2 | 0 | 10 | 7 | |
| Interest | 3 | 3 | 4 | 4 | 6 | 6 | 4 |
| Depreciation | 7 | 6 | 8 | 11 | 12 | 15 | 16 |
| Profit before tax | -4 | -4 | -16 | -5 | 7 | 31 | 30 |
| Tax % | 5% | 8% | 15% | 4% | -136% | 21% | |
| -5 | -5 | -19 | -4 | 25 | 32 | 26 | |
| EPS in Rs | -154.92 | -156.22 | -596.62 | -128.94 | 804.81 | 5.78 | 4.79 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 20% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 58% |
| 3 Years: | 70% |
| TTM: | -10% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 18% |
| 3 Years: | 32% |
| Last Year: | 22% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 11 | 11 |
| Reserves | 37 | 33 | 9 | 6 | 31 | 198 | 218 |
| 37 | 39 | 50 | 50 | 61 | 20 | 9 | |
| 31 | 34 | 43 | 40 | 46 | 60 | 28 | |
| Total Liabilities | 106 | 106 | 103 | 97 | 139 | 288 | 266 |
| 39 | 42 | 40 | 40 | 46 | 51 | 51 | |
| CWIP | 0 | 7 | 0 | 0 | 0 | 0 | 2 |
| Investments | 0 | 0 | 0 | 0 | 6 | 10 | 15 |
| 66 | 56 | 63 | 56 | 87 | 227 | 199 | |
| Total Assets | 106 | 106 | 103 | 97 | 139 | 288 | 266 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 12 | 10 | -2 | 14 | 8 | 44 | |
| -18 | -9 | 3 | -10 | -11 | -29 | |
| 6 | -0 | -4 | -1 | -3 | 111 | |
| Net Cash Flow | 0 | 0 | -3 | 3 | -5 | 125 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 64 | 64 | 54 | 46 | 47 | 56 |
| Inventory Days | 186 | 305 | 272 | 212 | 397 | |
| Days Payable | 197 | 273 | 245 | 197 | 585 | |
| Cash Conversion Cycle | 54 | 96 | 81 | 61 | 47 | -132 |
| Working Capital Days | 13 | 3 | -3 | -13 | 0 | 37 |
| ROCE % | 3% | -1% | 1% | 18% | 19% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
13 Nov - Read with Schedule III of SEBI (LODR) Regulations, 2015, please find enclosed copy of news paper publication dated November 13, 2025 in the Financial Express …
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
12 Nov - Q2FY26 earnings conference call audio posted on company website, Nov 12, 2025.
-
Corrigendum To The Unaudited Standalone And Consolidated Financial Results For The Second Quarter And Half Year Ended On September 30, 2025
12 Nov - Corrigendum: replaced standalone with consolidated cash flow; Q2/H1 Sep 30, 2025 figures unchanged.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
11 Nov - Q2FY26 consolidated revenue INR 722.7 Mn (YoY +26.5%); PAT INR 85.3 Mn.
- Announcement under Regulation 30 (LODR)-Investor Presentation 11 Nov
Concalls
-
Nov 2025TranscriptNotesPPT
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Feb 2025TranscriptNotesPPT
Leading Dental Company[1]
Laxmi Dental is the only end-to-end integrated dental products company in India. Based on FY23 revenue & PAT, the company is the largest and most profitable vertically integrated, indigenous B2B2C dental aligner solutions provider.